BridgeBio Pharma to discuss novel bioassay, Phase 2 data and preliminary Phase 3 trial design for BBP-418 in LGMD2i 03.21.2023 at 8:30 AM EDT Click here for webcast Supporting Materials BBIO – BBP-418 for LGMD2I/R9 – MDA 2023 – Oral Presentation – Phase 2 Data at 15 Months 2.5 MB BBIO – BBP-418 for LGMD2I/R9 – MDA 2023 – Poster – Phase 2 Data at 15 Months 2 MB BBIO – BBP-418 for LGMD2I/R9 – MDA 2023 – Preliminary Data on Bioassay Measuring ⍺DG 1.4 MB BBIO – BBP-418 for LGMD2I – MDA 2023 Webcast 3.4 MB